UPDATE: JPMorgan Downgrades Melinta Therapeutics Inc. (MLNT) to Underweight
Tweet Send to a Friend
(Updated - June 14, 2019 9:04 AM EDT)
(updated to add analyst comment)JPMorgan analyst Eric Joseph downgraded Melinta Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)JPMorgan analyst Eric Joseph downgraded Melinta Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
